De-escalation of Surgery for Melanoma

Questions and Discussion

Thursday, March 23, 2023

9:45 AM – 10:00 AM

Location: Ballroom C

Panelist(s)

Vernon K. Sondak, MD (he/him/his)

Chair, Department of Cutaneous Oncology
Moffitt Cancer Center
Tampa, Florida, United States

Disclosure(s): Alkermes: Independent Contractor (Ongoing); AmLO Biosciences: Advisor (Ongoing), Consultant (Ongoing); Bristol-Myers Squibb: Advisor (Ongoing), Consultant (Ongoing); Genesis Drug Discovery & Development: Independent Contractor (Ongoing); Iovance Biotherapeutics: Advisor (Ongoing), Consultant (Ongoing); Merck & Co., Inc.: Advisor (Ongoing), Consultant (Ongoing); Neogene Therapeutics: Research Grant (Ongoing); Novartis Pharmaceuticals Corporation: Advisor (Ongoing), Independent Contractor (Ongoing); Regeneron: Advisor (Ongoing), Consultant (Ongoing); SkylineDx: Research Grant (Ongoing); Turnstone Biologics: Contracted Research (Ongoing), Research Grant (Ongoing); Ultimovacs: Consultant (Ongoing)
Charlotte E. Ariyan, MD, PhD

Associate Attending, Gastric & Mixed Tumor Service
Memorial Sloan Kettering Cancer Center
New York, New York, United States

Disclosure(s): Amgen Inc. and Merck & Co., Inc.: Consultant (Terminated); Iovance Biotherapeutics: Consultant (Ongoing); pfizer: Ownership Interest (Ongoing)
Joseph Skitzki, MD (he/him/his)

Associate Professor of Surgical Oncology, Surgery, Immunology
Roswell Park Comprehensive Cancer Center, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Vernon K. Sondak, MD: Alkermes: Independent Contractor (Ongoing); AmLO Biosciences: Advisor (Ongoing), Consultant (Ongoing); Bristol-Myers Squibb: Advisor (Ongoing), Consultant (Ongoing); Genesis Drug Discovery & Development: Independent Contractor (Ongoing); Iovance Biotherapeutics: Advisor (Ongoing), Consultant (Ongoing); Merck & Co., Inc.: Advisor (Ongoing), Consultant (Ongoing); Neogene Therapeutics: Research Grant (Ongoing); Novartis Pharmaceuticals Corporation: Advisor (Ongoing), Independent Contractor (Ongoing); Regeneron: Advisor (Ongoing), Consultant (Ongoing); SkylineDx: Research Grant (Ongoing); Turnstone Biologics: Contracted Research (Ongoing), Research Grant (Ongoing); Ultimovacs: Consultant (Ongoing)

Charlotte E. Ariyan, MD, PhD: Amgen Inc. and Merck & Co., Inc.: Consultant (Terminated); Iovance Biotherapeutics: Consultant (Ongoing); pfizer: Ownership Interest (Ongoing)

Joseph Skitzki, MD: No financial relationships to disclose